We evaluated the accuracy of ABI in screening and evaluating PAOD in such a population.
我们研究了在这类高危人群中abi筛选及评估外周动脉阻塞性疾病的准确度。
Objective: To study the efficiency and safety of PGE1 - CD intravenous infusion in the treatment of PAOD.
目的：临床评价静脉给保达新(PGE1·CD)治疗PAOD的有效性及安全性。
The prevalence of PAOD in advanced elder with lipoprotein abnormalities is 2-3 times than in common elder.
高龄血脂异常患者PAOD的现患率是普通老年患者的2 - 3倍。
Buflomedil, a vasoactive agent, is used to treat the symptoms of peripheral arterial occlusive disease (PAOD).
丁咯地尔是一种血管活性物质，可用于外周动脉闭塞性疾病(POAD)的治疗。
Objective To investigate the prevalence of peripheral arteriosclerotic occlusive disease (PAOD) in elderly population with hyperlipemia.
目的了解周围动脉硬化闭塞症(PAOD)在老年血脂异常人群中的现患率。
Objective To detect the relationship of plasma fibrinogen, platelet aggregation rate and peripheral arterial occlusive disease (PAOD) in the elderly.
目的探讨血浆纤维蛋白原、血小板聚集对老年周围动脉硬化闭塞病(PAOD)的影响。
Objective:It is proved that Percutaneous Transluminal Angioplasty and Stenting is a effective treatment of PAOD, but its benefits is seriosly limited by local thrombotic occlusion and restenosis.
目的血管腔内支架成形术目前已被证明是治疗外周动脉硬化闭塞症（PAOD）的有效方法，然而术后出现的再狭窄影响了支架成形术的疗效。
Objective:It is proved that Percutaneous Transluminal Angioplasty and Stenting is a effective treatment of PAOD, but its benefits is seriosly limited by local thrombotic occlusion and restenosis.
目的血管腔内支架成形术目前已被证明是治疗外周动脉硬化闭塞症（PAOD）的有效方法，然而术后出现的再狭窄影响了支架成形术的疗效。
应用推荐